Newswise Breaking News Channel: Ebola

Dengue Fever Lands in LA: How Global Warming Is Affecting Health

Cedars-Sinai — Tue, 17 Sep 2024 17:05:21 EST

Amid southern california's recent record-breaking heat wave and fast-moving wildfires, public health officials reported the third locally acquired case of dengue fever in the los angeles area. Although the events seem unrelated, they actually are connected--and for troubling reasons.

LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives

La Jolla Institute for Immunology — Tue, 17 Sep 2024 17:05:16 EST

The new study, led by researchers in the Saphire Lab at LJI, reveals the inner workings of the Ebola virus nucleocapsid. LA JOLLA, CA--At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species.

Erica Ollmann Saphire wins 2023 Pantheon Award from California Life Sciences

La Jolla Institute for Immunology — Fri, 03 Nov 2023 13:05:14 EST

The award recognizes Saphire's leadership and innovative research toward addressing the urgent need for effective antibody therapeutics against COVID-19 and viral threats such as Ebola and Lassa virus.

Dr. Anthony Fauci to be awarded 2024 Inamori Ethics Prize by Inamori International Center for Ethics and Excellence

Case Western Reserve University — Wed, 25 Oct 2023 07:00:00 EST

The Inamori International Center for Ethics and Excellence at Case Western Reserve University will award Dr. Anthony Fauci, a physician, immunologist, and infectious disease expert, with the 2024 Inamori Ethics Prize.

Research analyzes relationship between agriculture, emergence of new diseases

Indiana University — Mon, 18 Sep 2023 09:00:00 EST

Researchers propose a new way of understanding how diseases spread between animals and humans, by focusing on the effect that agriculture, ecological and sociopolitical factors have on disease emergence and transmission.

A new look inside Ebola's "viral factories"

La Jolla Institute for Immunology — Wed, 09 Aug 2023 16:05:52 EST

The study, led by scientists at La Jolla Institute for Immunology (LJI), reveals the inner workings of viral factories, clusters of viral proteins and genomes that form in host cells.

Caring for the Community During the Next Pandemic

Cedars-Sinai — Tue, 20 Jun 2023 10:05:25 EST

Later this summer, staff members at Cedars-Sinai Marina del Rey Hospital will spring into action when a pretend patient comes to the Emergency Department with symptoms of a virus like Ebola, one of the deadliest, most infectious diseases on the planet.

Immigration Nation: Research and Experts

Newswise — Fri, 12 May 2023 15:30:08 EST

Title 42, the United States pandemic rule that had been used to immediately deport hundreds of thousands of migrants who crossed the border illegally over the last three years, has expired. Those migrants will have the opportunity to apply for asylum. President Biden's new rules to replace Title 42 are facing legal challenges. Border crossings have already risen sharply, as many migrants attempt to cross before the measure expires on Thursday night. Some have said they worry about tighter controls and uncertainty ahead. Immigration is once again a major focus of the media as we examine the humanitarian, political, and public health issues migrants must go through.

TRANSCRIPT AND VIDEO AVAILABLE Live Event for April 21: Sleeping pill reduces levels of Alzheimer's proteins

Newswise — Fri, 21 Apr 2023 15:10:43 EST

Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer's disease.

China reports world's first human death due to bird flu. Get the latest news and expert commentary on bird flu on the Avian Flu channel

Newswise — Wed, 12 Apr 2023 16:45:17 EST

Below are some of the latest headlines in the new Avian Flu channel on Newswise.

Speakers Announced for #DiscoverBMB

American Society for Biochemistry and Molecular Biology (ASBMB) — Tue, 07 Feb 2023 09:00:25 EST

Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, will feature award lectures by high-profile speakers discussing noteworthy research, education and diversity initiatives. The meeting will take place March 25-28 in Seattle.

LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection

La Jolla Institute for Immunology — Mon, 30 Jan 2023 16:30:56 EST

Inmazeb (REGN-EB3), developed by Regeneron, is a three-antibody cocktail designed to target the Ebola virus glycoprotein. The drug was first approved for clinical use in October 2020, but its exact mechanism of action has remained unclear.

Say Ahhh! Fruit Bat Gets a Check-up in the Republic of Congo

Wildlife Conservation Society — Tue, 24 Jan 2023 16:55:53 EST

The Wildlife Conservation Society (WCS) released an image of scientists taking a swab from a straw-colored fruit bat (Eidolon helvum) to test it for zoonotic diseases such as the Ebola virus.

MedStar Washington Hospital Center Opens Biocontainment Unit to Care for Patients Who Contract Highly Infectious Diseases

MedStar Washington Hospital Center — Thu, 19 Jan 2023 11:00:26 EST

MedStar Washington Hospital Center has opened a new state-of-the-art Biocontainment Unit (BCU) to care for patients who contract highly infectious diseases. Located near the Emergency Room, the new multi-purpose 15-bed unit will be used primarily for observation and flexed for respiratory isolation and further flexed to care for patients with highly contagious conditions, such as Ebola.

Texas Biomed at forefront of Sudan ebolavirus biomedical R&D

Texas Biomedical Research Institute — Mon, 19 Dec 2022 15:35:25 EST

A Sudan ebolavirus vaccine and antibody therapeutic tested at Texas Biomedical Research Institute have been sent to Uganda as part of efforts to control the outbreak there.

Dr. Fauci reflects on the perpetual challenge of infectious diseases

NIH, National Institute of Allergy and Infectious Diseases (NIAID) — Mon, 28 Nov 2022 12:20:32 EST

Once considered a potentially static field of medicine, the discipline of studying infectious diseases has proven to be dynamic as emerging and reemerging infectious diseases present continuous challenges, Anthony S. Fauci, M.D., writes in a perspective in The New England Journal of Medicine.

Bobby Brooke Herrera Joins Rutgers Global Health Institute as Principal Faculty Member

Rutgers University-New Brunswick — Fri, 28 Oct 2022 14:45:43 EST

Research scientist Bobby Brooke Herrera, renowned for developing tools to accelerate diagnosis and treatment of infectious diseases such as COVID-19, has joined Rutgers Global Health Institute.

Medical Researcher Aims to Glimpse Inside the "Minds" of Viral Killers

Rutgers University-New Brunswick — Tue, 27 Sep 2022 10:05:31 EST

Ricardo Rajsbaum understands killers. Like a criminal investigator tracking prey, the Rutgers virologist spends his days researching the enemy. Rather than obsessing over a madman's next move, however, Rajsbaum's focus is on the microscopic viruses that infect human cells - sometimes with deadly consequences.

Individual risk-factor data could help predict the next Ebola outbreak, new study shows

Lehigh University — Thu, 01 Sep 2022 16:05:36 EST

Several years ago, a team of scientists at Lehigh University developed a predictive model to accurately forecast Ebola outbreaks based on climate-driven bat migration.

Developing Antivirals for Pandemic-Level Viruses

University of Illinois Chicago — Wed, 10 Aug 2022 11:30:00 EST

Researchers at the University of Illinois Chicago are working with the National Institutes of Health and University of Minnesota to establish a center for antiviral drug development for pandemic-level viruses, including Ebola and SARS-CoV-2.